IP Library › Patent Application 17220791
Patent Application
App. No. 17/220,791

AQUEOUS HUMOR MONITORING DEVICES AND METHODS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/220,791
Abstract

A method for monitoring glucose concentration in aqueous humor can include inserting an implantable device into an eye and determining glucose concentration as a function of glucose sensed at the implantable device. The method can optionally include optically detecting glucose concentration as a function of polarimetry and/or fluorescence. A system for monitoring glucose concentration can include devices described herein.

Claims (24)

1 . A system for monitoring glucose concentration in aqueous humor, the system comprising:

an implantable device configured to be implanted in an eye and defining a lumen configured to transmit aqueous humor from an interior portion of the eye to an exterior of the eye; and

a contact lens configured to be worn on the exterior of the eye and including a holding area for the aqueous humor transmitted through the lumen to the exterior of the eye, the contact lens including a sensor, the sensor responsive to the glucose concentration of the aqueous humor transmitted through the lumen to the exterior of the eye.

2 . The system of claim 1 , wherein the contact lens further comprises an antenna for wireless transmissions of signals indicative of the glucose concentration.

3 . The system of claim 2 , wherein the antenna comprises an energy transfer antenna.

4 . The system of claim 1 , wherein the contact lens includes a localized ballast region that is comparatively heavier than other portions of the contact lens.

5 . The system of claim 1 , wherein the holding area comprises a well.

6 . The system of claim 1 , wherein the sensor comprises an electrochemical enzymatic glucose sensor.

7 . The system of claim 1 , wherein the contact lens defines one or more channels.

8 . The system of claim 1 , wherein the holding area is an area of the contact lens at which the aqueous humor transmitted through the lumen to the exterior of the eye will tend to collect.

9 . The system of claim 8 , wherein the sensor is adjacent to the holding area.

10 . The system of claim 1 , wherein the contact lens includes a controller.

11 . A method for monitoring glucose concentration in aqueous humor, the method comprising:

implanting an implantable device in an eye, the implantable device defining a lumen configured to transmit aqueous humor from an interior portion of the eye to an exterior of the eye; and

providing a contact lens configured to be worn on the exterior of the eye, the contact lens including a holding area for the aqueous humor transmitted through the lumen to the exterior of the eye, the contact lens including a sensor, the sensor responsive to the glucose concentration of the aqueous humor transmitted through the lumen to the exterior of the eye.

12 . The method of claim 11 , wherein the aqueous humor transmitted through the lumen to the exterior of the eye collects at the holding area.

13 . The method of claim 12 , wherein the sensor measures the glucose concentration of the aqueous humor in the holding area.

14 . The method of claim 11 , wherein the contact lens includes a localized ballast region that is comparatively heavier than other portions of the contact lens.

15 . The method of claim 14 , wherein the implantable device is implanted in the eye relative to the contact lens at a location that is opposite of a location of the localized ballast region.

16 . The method of claim 11 , wherein the sensor comprises an electrochemical enzymatic glucose sensor.

17 . The method of claim 11 , further comprising delivering energy to the contact lens from an external source using an energy transfer antenna in the contact lens.

18 . The method of claim 11 , further comprising wirelessly transmitting, from the contact lens, signals indicative of the glucose concentration measured by the sensor.

19 . The method of claim 18 , further comprising receiving, by a smart phone or other electronic device, the wirelessly transmitted signals indicative of the glucose concentration.

20 . The method of claim 11 , wherein the implantable device is implanted in the eye such that the implantable device is spaced apart from the contact lens that is worn on the exterior of the eye.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2023
From: MICROOPTX, INC.
To: INNOMEDEX LLC
Reel/Frame 063003/0724 →